tetano
Editor, Senior Moderator
Clin Vaccine Immunol. 2012 Aug 8. [Epub ahead of print]
Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.
Shimizu M, Ueno K, Yachie A.
Source
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, 920-8641, Japan.
Abstract
We report the case of a patient with systemic juvenile idiopathic arthritis (s-JIA) receiving tocilizumab (TCZ) who experienced relapses of s-JIA after receiving influenza vaccination. Systemic symptoms of s-JIA could be masked during TCZ therapy. Careful observation with the monitoring of serum interleukin (IL)-18 and IL-6 levels may be useful.
PMID:
22875602
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22875602
Relapse of systemic juvenile idiopathic arthritis after influenza vaccination in a patient receiving tocilizumab.
Shimizu M, Ueno K, Yachie A.
Source
Department of Pediatrics, School of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, 13-1 Takaramachi, Kanazawa, 920-8641, Japan.
Abstract
We report the case of a patient with systemic juvenile idiopathic arthritis (s-JIA) receiving tocilizumab (TCZ) who experienced relapses of s-JIA after receiving influenza vaccination. Systemic symptoms of s-JIA could be masked during TCZ therapy. Careful observation with the monitoring of serum interleukin (IL)-18 and IL-6 levels may be useful.
PMID:
22875602
[PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/22875602